iCliniq Logo
HomeAnswersPulmonology (Asthma Doctors)tezepelumab

Does Tezepelumab worsen kidney function?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

I am a 57-year-old female with severe eosinophilic asthma. My doctor wants to start me on Tezspire, but I also have autoimmune thyroiditis and mild kidney issues (creatinine around 1.4). Are biologics like this safe in people with autoimmune conditions and minor renal impairment? Could this worsen my kidney function or impact my thyroid medicine?

Please help.

Thank you.

Answered by Dr. Fizza Noor

Hello,

Welcome to icliniq.com.

I can understand your concern.

Your concerns are correct in starting Tezspire (Tezepelumab) while having autoimmune thyroiditis and mild kidney issues. I will provide a detailed analysis below, including probable causes, necessary investigations, diagnosis, and a personalized treatment and follow-up plan for your case.

The probable causes:

  1. Chronic eosinophilic airway inflammation.

  2. Autoimmune dysregulation due to thyroiditis.

  3. Age-related decline in renal function or autoimmune-associated nephropathy.

Investigations to be done:

  1. Complete blood count (CBC) with differential (especially eosinophils).

  2. Serum creatinine, BUN (blood urea nitrogen), and estimated GFR (glomerular filtration rate).

  3. Urinalysis for proteinuria or sediment.

  4. Thyroid function tests: TSH (thyroid-stimulating hormone), FT4 (free thyroxine), anti-TPO (thyroid peroxidase) antibodies.

  5. Liver function tests (baseline before starting Tezspire).

  6. Chest imaging if recent worsening of symptoms.

Differential diagnosis:

  1. Severe eosinophilic asthma.

  2. Autoimmune thyroiditis with systemic immune activity.

  3. Early-stage chronic kidney disease.

  4. Drug-induced nephropathy (if on other medications).

  5. Allergic bronchopulmonary aspergillosis (if clinical suspicion exists).

Probable diagnosis:

  1. Severe eosinophilic asthma in a patient with autoimmune thyroiditis and mild chronic kidney disease (likely Stage 2–3a).

Treatment plan:

  1. Initiate Tezspire (Tezepelumab) after baseline labs.

  2. Monitor thyroid function and renal profile regularly.

  3. Continue thyroid medication (Levothyroxine) with dose adjustments as per TSH.

  4. Avoid NSAIDs (non-steroidal anti-inflammatory drugs) and nephrotoxic medications.

  5. Maintain good hydration.

  6. Review asthma symptoms and peak flow readings monthly.

Regarding follow-up:

  1. First review: two to four weeks after Tezspire initiation.

  2. Then, monthly for asthma control and every three months for renal and thyroid function assessment.

  3. Adjust treatment based on symptom control and lab trends.

Preventive measures:

  1. Annual influenza and pneumococcal vaccination.

  2. Avoid known asthma triggers.

  3. Monitor for signs of adverse drug reactions or infections.

  4. Regular follow-ups should be maintained for renal and thyroid monitoring.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.

Answered byDr. Fizza Noor

Medically reviewed byiCliniq medical review team

Published At July 8, 2025
Reviewed AtJuly 10, 2025

Same symptoms don't mean you have the same problem. Consult a doctor now!

Dr. Fizza Noor
Dr. Fizza Noor

Pediatric Allergy/Asthma Specialist

Consult this doctor
Listen to related tracks in our music library

Read answers about:

kidney functiontezepelumab

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.